Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-α2a (IFNα) and interleukin 2 (IL-2) with or without cisplatin

✍ Scribed by U. Keilholz; P. Martus; C.J.A. Punt; W. Kruit; G. Mooser; D. Schadendorf; D. Liénard; R. Dummer; J. Koller; C. Voit; A.M.M. Eggermont

• Book ID: 117658971
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 166 KB
• Volume: 38
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(02)00123-5